These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2573328)

  • 21. P300 abnormality in schizophrenic subtypes.
    St Clair D; Blackwood D; Muir W
    J Psychiatr Res; 1989; 23(1):49-55. PubMed ID: 2569037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia.
    Duncan EJ; Szilagyi S; Efferen TR; Schwartz MP; Parwani A; Chakravorty S; Madonick SH; Kunzova A; Harmon JW; Angrist B; Gonzenbach S; Rotrosen JP
    Psychopharmacology (Berl); 2003 Apr; 167(1):63-71. PubMed ID: 12632245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Auditory evoked potentials as possible predictors of outcome in schizophrenic outpatients.
    Hegerl U; Gaebel W; Gutzman H; Ulrich G
    Int J Psychophysiol; 1988 Aug; 6(3):207-14. PubMed ID: 2900230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Auditory and visual P300 reflecting cognitive improvement in patients with schizophrenia with quetiapine: a pilot study.
    Park EJ; Han SI; Jeon YW
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):674-80. PubMed ID: 20304022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Auditory selective attention and event-related potentials in schizophrenia.
    Ward PB; Catts SV; Fox AM; Michie PT; McConaghy N
    Br J Psychiatry; 1991 Apr; 158():534-9. PubMed ID: 2054568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Premature disinhibition of P3 generation in schizophrenia.
    Shelley AM; Grochowski S; Lieberman JA; Javitt DC
    Biol Psychiatry; 1996 Apr; 39(8):714-9. PubMed ID: 8731459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novelty P3 and P3b in first-episode schizophrenia and chronic schizophrenia.
    Devrim-Uçok M; Keskin-Ergen HY; Uçok A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1426-34. PubMed ID: 16828218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Event-related potentials in alcoholic men: P3 amplitude reflects family history but not alcohol consumption.
    Pfefferbaum A; Ford JM; White PM; Mathalon D
    Alcohol Clin Exp Res; 1991 Oct; 15(5):839-50. PubMed ID: 1755518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in auditory P3 event-related potential in schizophrenia and depression.
    Blackwood DH; Whalley LJ; Christie JE; Blackburn IM; St Clair DM; McInnes A
    Br J Psychiatry; 1987 Feb; 150():154-60. PubMed ID: 2888501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients.
    Braff DL; Swerdlow NR; Geyer MA
    Am J Psychiatry; 1999 Apr; 156(4):596-602. PubMed ID: 10200740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Auditory and visual event-related potentials in alcoholics: abnormalities of components and brain electrical field.
    Olbrich HM; Maes H; Gann H; Hagenbuch F; Feige B
    Eur Arch Psychiatry Clin Neurosci; 2000; 250(5):215-20. PubMed ID: 11097163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.
    Stefánsson SB; Jónsdóttir TJ
    Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topographic abnormalities of P3 in schizotypal personality disorder.
    Salisbury DF; Voglmaier MM; Seidman LJ; McCarley RW
    Biol Psychiatry; 1996 Aug; 40(3):165-72. PubMed ID: 8830949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of medication history on midlatency auditory evoked responses in schizophrenia.
    Erwin RJ; Shtasel D; Gur RE
    Schizophr Res; 1994 Feb; 11(3):251-8. PubMed ID: 7910754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased distractibility in schizophrenic patients. Electrophysiologic and behavioral evidence.
    Grillon C; Courchesne E; Ameli R; Geyer MA; Braff DL
    Arch Gen Psychiatry; 1990 Feb; 47(2):171-9. PubMed ID: 2302027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P300 topographic asymmetries are present in unmedicated schizophrenics.
    Faux SF; McCarley RW; Nestor PG; Shenton ME; Pollak SD; Penhune V; Mondrow E; Marcy B; Peterson A; Horvath T
    Electroencephalogr Clin Neurophysiol; 1993; 88(1):32-41. PubMed ID: 7681389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Brain evoked potentials in patients with Alzheimer's disease and schizophrenia: a comparative study].
    Chen X; Zhang M; Wang J
    Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):674-6. PubMed ID: 11038791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Replication of an evoked potential study of lateralized hemispheric dysfunction in schizophrenics.
    Roemer RA; Shagass C
    Biol Psychiatry; 1990 Aug; 28(4):275-91. PubMed ID: 1975754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients.
    Adler LE; Olincy A; Cawthra EM; McRae KA; Harris JG; Nagamoto HT; Waldo MC; Hall MH; Bowles A; Woodward L; Ross RG; Freedman R
    Am J Psychiatry; 2004 Oct; 161(10):1822-8. PubMed ID: 15465979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Event-related potentials in schizophrenic patients during a degraded stimulus version of the visual continuous performance task.
    Knott V; Mahoney C; Labelle A; Ripley C; Cavazzoni P; Jones B
    Schizophr Res; 1999 Feb; 35(3):263-78. PubMed ID: 10093872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.